HYEP IVAN (Chief Financial Officer) sold 8.8% of their position (12.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $349.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001470831-26-000814
Officer· Chief Financial Officer
Since Mar 2026
-12.50K
Net shares
Net seller
$349.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
$3.79
Trade value
$47.37K
% of position
9.6%
8/10/2026
129.85K→142.35K
Common Stock
Direct
Shares
−12.50K
Price / share
$27.97
Trade value
$349.59K
% of position
8.8%
8/10/2026
142.35K→129.85K
Total
Net shares
+0.00
Net value
-$302.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +12.50K | $3.79 | $47.37K | 9.6% | 129.85K | 142.35K |
| Common Stock Direct | 8/10/2026 | S · Sale | −12.50K | $27.97 | $349.59K | 8.8% | 142.35K | 129.85K |
| Total | +0.00 | -$302.22K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
3.7898
Held after
26.34K
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 8/10/2026 | M · Option Exercise | −12.50K | 3.7898 | — | 26.34K |